In conclusion, the present study found that SCARA5 exhibited aberrant low expression in ESCC tissues and cell lines, which mainly expressed in the membrane, and which can inhibit proliferation and metastasis of ESCC cells, and induce ferroptosis of ESCC cells. Here, SCARA5 is linked to esophageal squamous cell carcinoma.